Cancer News and Research

Latest Cancer News and Research

Exercise cuts colon cancer risk by a quarter

Engaging in physical activity can reduce your chances of developing the most common kind of bowel cancer by a quarter, according to new research published in the British Journal of Cancer.

11 Feb 2009

Compound can distinguish between benign tissue and localized and metastatic prostate cancer

Researchers have determined that a molecule produced by the bodys metabolism could be used to differentiate between benign prostate tissue vs. localized and metastatic prostate cancer.

11 Feb 2009

Bone marrow transplant patients may benefit from new immune research

Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.

11 Feb 2009

ViroPharma reports results of trial for Maribavir in bone marrow transplant patients

ViroPharma Incorporated has announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.

10 Feb 2009

Sundia MediTech and Xcovery announce new drug discovery

Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA.

10 Feb 2009

Race and ethnicity affect use of hospice services among patients with advanced cancer

Race and ethnicity appear to have an effect on whether a patient with terminal cancer uses hospice care services, according to a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

10 Feb 2009

Researchers identify mutation that causes inflammatory bowel disease

A team of scientists at The Scripps Research Institute has linked a mouse mutation to an increased susceptibility for developing inflammatory bowel disease -- represented in humans as Crohn's disease and ulcerative colitis, which together are estimated to affect more than a million people in the United States.

10 Feb 2009

Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma

atients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomized trials in the February 10 online issue of the Journal of the National Cancer Institute.

10 Feb 2009

Costs of digestive diseases grown to more than $141 billion a year

Digestive, liver and pancreatic diseases result in more than 100 million outpatient visits and 13 million hospitalizations annually at a cost of $141.8 billion.

10 Feb 2009

New weapon in the battle against obesity

A new system proposed by Canadian and US obesity researchers may provide another weapon in the battle against obesity.

10 Feb 2009

New guidelines for prescribing opioid pain drugs

A prestigious panel of pain-management experts representing the American Pain Society (APS) www.ampainsoc.org and the American Academy of Pain Medicine (AAPM) has published the first comprehensive clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.

10 Feb 2009

Targeted immune cells shrink tumors in mice

Researchers have generated altered immune cells that are able to shrink, and in some cases eradicate, large tumors in mice.

10 Feb 2009

Gene controllers crucial for cancer spread

Cancer Research UK scientists have pinpointed two proteins that work together to help cancer cells spread around the body, reveals a study published in Nature Cell Biology.

10 Feb 2009

FDA approves clinical studies of novel anti-cancer drug developed by Italian researchers

Nerviano Medical Sciences (NMS) has secured Food and Drug Administration (FDA) approval to conduct for the first time clinical trials of a novel antitumoral agent.

10 Feb 2009

Endo Pharmaceuticals announces research collaborations on novel pain treatments and potential cancer treatments

Endo Pharmaceuticals has announced that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.

10 Feb 2009

New drug short-circuits cancer growth

A new drug that blocks cancer's main source of growth has been created in the lab and proven effective in mice, scientists are reporting.

10 Feb 2009

Clinicians override most electronic medication safety alerts

Computer-based systems that allow clinicians to prescribe drugs electronically are designed to automatically warn of potential medication errors, but a new study reveals clinicians often override the alerts and rely instead on their own judgment.

10 Feb 2009

Experts say multivitamins have no impact on older women's risk of cancer or heart disease

A study by scientists in the United States has found that the long-term use of multivitamins have no impact on a postmenopausal woman's risk of cancer or heart disease.

10 Feb 2009

UT Southwestern develops medically supervised liquid diet program

UT Southwestern Medical Center's bariatric program has developed a medically supervised program using a specially designed liquid protein diet for people looking to lose weight with or without surgery.

9 Feb 2009

Pregnancy has no impact on breast cancer, but can delay diagnosis and treatment

A new study finds women who develop breast cancer while pregnant or soon afterwards do not experience any differences in disease severity or likelihood of survival compared to other women with breast cancer.

9 Feb 2009